Treatment of Angelman syndrome using ASO targeting UBE3A-AS

This program supported further exploration of various ASO candidates for paternal gene activation through antisense technology.

Share
Facebook
Twitter
LinkedIn
Email
Foundation Updates
Rare Disease Week: Washington, DC Round-up
Rare Disease Week: Washington, DC Round-up
International Angelman Day 2023 Global News Roundup
International Angelman Day 2023 Global News Roundup
Research Updates
Learn more about the ORCA measure
Learn more about the ORCA measure
FAST attends the American Society of Gene & Cell Therapy’s annual scientific meeting
FAST attends the American Society of Gene & Cell Therapy’s annual scientific meeting